Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease.

Charytan DM, Desai M, Mathur M, Stern NM, Brooks MM, Krzych LJ, Schuler GC, Kaehler J, Rodriguez-Granillo AM, Hueb W, Reeves BC, Thiele H, Rodriguez AE, Buszman PP, Buszman PE, Maurer R, Winkelmayer WC.

Kidney Int. 2016 Aug;90(2):411-21. doi: 10.1016/j.kint.2016.03.033.

PMID:
27259368
3.

Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus.

Sprandel MC, Hueb WA, Segre A, Ramires JA, Kalil-Filho R, Maranhão RC.

Cardiovasc Diabetol. 2015 Aug 14;14:107. doi: 10.1186/s12933-015-0270-8.

4.

Conservative strategy for treatment of stable coronary artery disease.

Rezende PC, Scudeler TL, da Costa LM, Hueb W.

World J Clin Cases. 2015 Feb 16;3(2):163-70. doi: 10.12998/wjcc.v3.i2.163. Review.

5.

Myocardial ischemia is a key factor in the management of stable coronary artery disease.

Iwasaki K.

World J Cardiol. 2014 Apr 26;6(4):130-9. doi: 10.4330/wjc.v6.i4.130. Review.

6.

Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease.

Harskamp RE, Williams JB, Halkos ME, Lopes RD, Tijssen JG, Ferguson TB Jr, de Winter RJ.

J Thorac Cardiovasc Surg. 2014 Nov;148(5):1837-42. doi: 10.1016/j.jtcvs.2014.03.028. Review.

7.

Comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease: a meta-analysis.

Li X, Kong M, Jiang D, Dong A.

Interact Cardiovasc Thorac Surg. 2014 Mar;18(3):347-54. doi: 10.1093/icvts/ivt509. Review.

8.
9.

Drug-eluting coronary stents - focus on improved patient outcomes.

Jaffery Z, Prasad A, Lee JH, White CJ.

Patient Relat Outcome Meas. 2011 Jul;2:161-74. doi: 10.2147/PROM.S24796.

10.

Loss of short-term symptomatic benefit in patients with an occluded infarct artery is unrelated to non-protocol revascularization: results from the Occluded Artery Trial (OAT).

Devlin G, Reynolds HR, Mark DB, Rankin JM, Carvalho AC, Vozzi C, Sopko G, Caramori P, Džavík V, Ragosta M, Forman SA, Lamas GA, Hochman JS.

Am Heart J. 2011 Jan;161(1):84-90. doi: 10.1016/j.ahj.2010.09.009.

11.

Simultaneous hybrid coronary revascularization reduces postoperative morbidity compared with results from conventional off-pump coronary artery bypass.

Kon ZN, Brown EN, Tran R, Joshi A, Reicher B, Grant MC, Kallam S, Burris N, Connerney I, Zimrin D, Poston RS.

J Thorac Cardiovasc Surg. 2008 Feb;135(2):367-75. doi: 10.1016/j.jtcvs.2007.09.025.

12.

Will drug-eluting stents replace coronary artery bypass surgery?

Reul RM.

Tex Heart Inst J. 2005;32(3):323-30. Review.

13.
14.

Revascularisation in diabetics with multivessel coronary artery disease.

Beatt KJ, Morgan KP, Kapur A.

Heart. 2004 Sep;90(9):999-1002. Review. No abstract available.

15.
16.

Coronary artery bypass surgery versus coronary stenting: risk-adjusted survival rates in 5,619 patients.

Villareal RP, Lee VV, Elayda MA, Wilson JM.

Tex Heart Inst J. 2002;29(1):3-9.

17.

Coronary artery disease: part 2. Treatment.

Link N, Slater W.

West J Med. 2001 May;174(5):330-5. No abstract available.

18.

Studies in meta-analysis of treatment of stable angina had methodological flaws.

Eccleshall SC, Laarman GJ, Nolan J.

BMJ. 2000 Dec 2;321(7273):1408. No abstract available.

20.

Treatment of stable angina. Use drugs before percutaneous transluminal coronary angioplasty.

Lüscher TF.

BMJ. 2000 Jul 8;321(7253):62-3. No abstract available.

Items per page

Supplemental Content

Support Center